or Try an Advanced Search...

    Technical Analysis for CDIO - Cardio Diagnostics Holdings Inc.

    Grade Last Price % Change Price Change
    F 0.24 -6.04% -0.02
    CDIO closed down 6.04 percent on Wednesday, November 20, 2024, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical CDIO trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish -6.04%
    Fell Below 50 DMA Bearish -6.04%
    Inside Day Range Contraction -6.04%
    Wide Bands Range Expansion -6.04%
    Oversold Stochastic Weakness -6.04%
    20 DMA Resistance Bearish -8.26%
    Older End-of-Day Signals for CDIO ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    50 DMA Resistance about 22 hours ago
    Down 5% about 22 hours ago
    Fell Below Previous Day's Low about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CDIO Chart by TradingView
    Basic chart:

    Profile

    Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. Cardio was formed to further develop and commercialize a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become one of the leading medical technology companies for enabling improved prevention, early detection, and assists in treatment of cardiovascular disease.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Artificial Intelligence Medical Technology Cardiovascular Disease Epigenetics Preventive Healthcare Treatment Of Cardiovascular Disease

    Is CDIO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 16 Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations
    Nov 12 Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
    Oct 29 Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
    Oct 1 Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
    Sep 17 Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests
    Jul 29 Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
    Jun 27 Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
    Jun 25 Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum
    Jun 10 Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
    May 21 Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests
    See more CDIO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.56
    52 Week Low 0.19
    Average Volume 3,481,111
    200-Day Moving Average 0.71
    50-Day Moving Average 0.26
    20-Day Moving Average 0.30
    10-Day Moving Average 0.32
    Average True Range 0.06
    RSI (14) 43.18
    ADX 39.81
    +DI 26.37
    -DI 20.78
    Chandelier Exit (Long, 3 ATRs) 0.35
    Chandelier Exit (Short, 3 ATRs) 0.37
    Upper Bollinger Bands 0.41
    Lower Bollinger Band 0.18
    Percent B (%b) 0.29
    BandWidth 80.80
    MACD Line 0.00
    MACD Signal Line 0.01
    MACD Histogram -0.0106
    Fundamentals Value
    Market Cap 5.15 Million
    Num Shares 21.1 Million
    EPS -0.71
    Price-to-Earnings (P/E) Ratio -0.34
    Price-to-Sales 3072.73
    Price-to-Book 16.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.29
    Resistance 3 (R3) 0.29 0.28 0.28
    Resistance 2 (R2) 0.28 0.27 0.28 0.28
    Resistance 1 (R1) 0.26 0.26 0.26 0.26 0.28
    Pivot Point 0.25 0.25 0.24 0.25 0.25
    Support 1 (S1) 0.23 0.24 0.22 0.23 0.21
    Support 2 (S2) 0.22 0.23 0.21 0.21
    Support 3 (S3) 0.20 0.22 0.20
    Support 4 (S4) 0.20